Story at a glance
- Six in 10 respondents said it is not very, or not at all, likely they would get the first generation of a vaccine.
- Thirty-nine percent said they would.
- The poll comes amid questions about the potential politicization of a coronavirus vaccine.
A new poll shows more Americans are becoming more reluctant to get a coronavirus vaccine as soon as one becomes available as the U.S. has recorded nearly 7 million COVID-19 infections and more than 200,000 deaths.
The latest Axios/Ipsos coronavirus poll found 60 percent of respondents said it is not very, or not at all, likely they would get the first generation of a COVID-19 vaccine when it’s ready compared to 39 percent who said they would.
The results from the poll of a nationally representative probability sample of 1,008 adults conducted from Sept. 18-21 shows an 8 percentage point drop from August, when 47 percent said they would be willing to get the first vaccine.
Only 9 percent said they’re very likely to take the first-generation vaccine, a drop from 17 percent in August, while 33 percent said they’re not at all likely to take the vaccine, an increase from 26 percent last month.
Thirty-percent of those surveyed said they plan to get the vaccine a few months after it becomes available, while 13 percent said they would try to get it immediately; 16 percent would get it after a few weeks, 18 percent said it’s likely they would wait a year or longer and 23 said they wouldn’t get it at all.
More than 40 percent of Democrats said they would be likely or somewhat likely to get the first generation of vaccines as soon as it’s available, compared to 33 percent of Republicans. Members of both parties were less likely to get a vaccine as soon as possible compared to August.
BREAKING NEWS ABOUT THE CORONAVIRUS PANDEMIC IN AMERICA
The poll comes amid questions about the potential politicization of a coronavirus vaccine, as President Trump’s timeline for manufacturing and distributing a safe and effective vaccine has been at odds with what public health experts have projected.
The president has insisted that a vaccine could be made available to high risk individuals and health care workers as early as October, ahead of the Nov. 3 presidential election. But Centers for Disease Control and Prevention Director Robert Redfield and National Institutes for Allergy and Infectious Diseases Director Anthony Fauci have said it’s more likely an effective vaccine won’t be ready until November or December.
While Trump on Friday said the U.S. will produce enough coronavirus vaccine doses for every American by April 2021, Redfield has said a vaccine likely wouldn’t be broadly available until the late second quarter or third quarter of 2021.
A poll earlier this month found a majority of Americans are concerned a COVID-19 vaccine will be rushed to the market before it's ready due to political pressure from the Trump administration.
The Kaiser Family Foundation survey found 62 percent of respondents said they were concerned about a vaccine being authorized by the Food and Drug Administration (FDA) before it is proven to be safe and effective.
WHAT YOU NEED TO KNOW ABOUT CORONAVIRUS RIGHT NOW